imatinib mesylate
P9973
Phase 1 small_molecule completed
Quick answer
imatinib mesylate for Leukemia is a Phase 1 program (small_molecule) at Children's Hospital of Fudan University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Children's Hospital of Fudan University
- Indication
- Leukemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed